research progress of matrix metalloproteinase 12 in non-small cell lung cancer

Clicks: 152
ID: 245023
2014
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Lung cancer is one of the most common malignant tumors in the world wide. Non-small cell lung cancer (NSCLC) accounts for approximately 80% of lung cancers, its pathogenesis have not been elucidated. Recently, researches have shown that dysregulation and excessive activity of the matrix metalloproteinases (MMPs) has been associated with many pathologies. Some results suggest that the matrix metalloproteinases 12 (MMP-12) participates in the invasion and metastasis of NSCLC. The expression of MMP-12 in non-small cell lung cancer is significantly higher than in adjacent tissues. And studies have shown that the MMP-12 has important prognostic significance in NSCLC. Therefore this article will briefly summarize the research progresses of MMP-12 in NSCLC.
Reference Key
wen2014chineseresearch Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Yuan WEN;Li CAI
Journal proceedings of the 10th acm multimedia systems conference, mmsys 2019
Year 2014
DOI 10.3779/j.issn.1009-3419.2014.01.05
URL
http://dx.doi.org/10.3779/j.issn.1009-3419.2014.01.05
Keywords
lung neoplasms Oncology including cancer and carcinogens tumors matrix metalloproteinases 12neoplasms

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.